VTRS

Nasdaq

Viatris Inc

Health Care, Pharmaceuticals

$16.43

close 7 Aug 2026

+66.63%

52-week change

$18.87B

market cap

$9.43

$18.39

52-week range

Expected price

$0.48 – $0.59

Current price

$16.43

Signal

Could be overvalued

A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.

Current multiples

P/E (TTM)-47.53x

P/S (TTM)1.28x

P/B1.32x

EV/EBITDA (TTM)11.56x

FCF yield (TTM)10.36%

PEG (TTM, GAAP)—

Context

P/E, own 5-year average46.79x

P/E, sector median29.65x*

Price at 5-year median P/E—*

Indicated dividend yield2.92%

Forward — analyst consensus

Forward P/E (FY2026)6.66x*

Forward P/E (FY2027)6.22x

Forward PEG0.94*

Consensus EPS FY2026 (8 analysts)$2.47

EPS growth (FY2026→FY2027)7.09%

Revenue growth (FY2026)3.38%

Street view

Price target (mean)$18.44*

Target upside12.22%

Ratings (buy / hold / sell)5 / 4 / 1

FY2026 EPS revisions, 30d (up / down)1 / 2

5-year history

Dashed line: average of month-end values

P/E (TTM)

P/S (TTM)

P/B

FCF yield (TTM)

Dividend yield

period to 30 Jun 2026, filed 6 Aug 2026, close 7 Aug 2026

Discounted cash flow

Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.

Free cash flow, last ten years and TTM

5Y CAGR +14.40%

Assumptions

Growth rate, years 1–10%

Perpetual growth%Discount rate%

Base FCF$M

As filed — not assumptions

Current price$16.43

Cash & equivalents$886.50M

Total debt$13.35B

Shares outstanding1.15B

Result

DCF price per share$69.23

Current price$16.43

Margin of safety+321.38%

PV of years 1–10$27.20B

PV of terminal value$64.79B

Equity value$79.52B

Market-implied growth+0.57%

Projected FCF, years 1–10

Hover for PV and growth

Projection detail

Override growth for any year; blank years use the uniform rate

Year	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035	Terminal
Growth, %											2.5
FCF	$2.24B	$2.56B	$2.93B	$3.35B	$3.83B	$4.38B	$5.01B	$5.73B	$6.56B	$7.51B	$139.87B
PV	$2.07B	$2.19B	$2.32B	$2.46B	$2.61B	$2.76B	$2.92B	$3.10B	$3.28B	$3.48B	$64.79B

period to 30 Jun 2026, filed 6 Aug 2026, close 7 Aug 2026